DECIPHERA PHARMACEUTICALS INC earnings per share and revenue

D05 earnings per share for the last quarter are -0.48 EUR whereas the estimation was -0.51 EUR which accounts for 6.19% surprise. Företagets omsättning för samma period uppgår till 41.98 M EUR trots den uppskattade siffran 42.82 M EUR. Estimated earnings per share for the next quarter are -0.47 EUR, and revenue is expected to reach 46.43 M EUR. Also watch annual changes over time to get a bigger picture of D05 earnings per share and revenue dynamics.